Concepedia

Publication | Open Access

Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study

DOIFull Paper Access

53

Citations

43

References

2022

Year

Marguerite Burns, Lu Tang, Chung‐Chou H. Chang, Joo Yeon Kim, Katherine A. Ahrens, Lindsay Allen, Peter Cunningham, Adam J. Gordon, Marian Jarlenski, Paul Lanier,
Addiction

Abstract

Continuation of medication for opioid use disorder (MOUD) in US Medicaid beneficiaries was associated with a substantial reduction in overdose risk up to 12 months after the first claim for MOUD.

References

YearCitations

Page 1